

Xi yang shen, Tienchi ginseng, western ginseng, five-fingers
Derived from the root of the plant. Most American ginseng is cultivated at the northwest region of United States and Canada. Patients take this supplement to improve athletic performance, strength, and stamina, and to treat diabetes and cancer. In Chinese herbal formulas, American ginseng is frequently used to nourish ‘Yin’ (1). The saponin glycosides, also known as ginsenosides or panaxosides, are thought responsible for American ginseng’s effects, but there is limited laboratory or clinical research for this species.
Ginsenosides have both stimulatory and inhibitory effects on the CNS (4), alter cardiovascular tone, enhance humoral and cellular-dependent immunity, and have anticancer effects in vitro (3) (15) (16). The anticancer effects of ginseng were enhanced when combined with antioxidants (14). Ginseng also acts synergistically with 5-fluorouracil against colorectal cancer cells (17) and demonstrated radioprotective effects in irradiated human lymphocytes (18). Data from an epidemiological study showed that ginseng improves survival and quality of life in breast cancer patients (13).
American ginseng may increase the hypoglycemic effect of insulin and sulfonylureas (7). A recent study has shown that ginseng may reduce the efficacy of warfarin (11). Limited data suggest that it may improve glucose control in diabetics (2) (6), but additional research is necessary. Results from a randomized controlled trial indicate that ginseng has a modest effect on reducing the number and severity of colds (12). However, further research must be performed to determine efficacy and optimal dose of American ginseng for all proposed uses.
Ginsenosides are thought responsible for American ginseng’s activity, although the exact mechanism of action is unknown. American ginseng lowers serum glucose and may affect carbohydrate metabolism (2) (6). Related species, such as Panax ginseng, have been the focus of most laboratory and clinical research. Experiments using extracts from these species indicate that ginsenosides stimulate and inhibit the CNS (4). The extracts also stimulate TNF alpha production by alveolar macrophages (10). The Rg1 ginsenoside is associated with improvements in humoral and cell-mediated immune response and increases in T helper cells, T lymphocytes, and NK cells in mice (5). Anticancer activity has been shown in vitro for several ginsenosides (3). Ginseng’s antagonistic effect on warfarin is not due to vitamin K (11).
Evaluation of A1, A2, B2, and C ginsenosides in the rabbit suggests one compartment pharmacokinetics for all ginsenosides following intravenous administration. Elimination half-lives range from 20-500 minutes. Ginsenoside A1 is rapidly absorbed after intraperitoneal administration. All ginsenosides are primarily eliminated unchanged in the urine.
(1)
Breast cancer patients should use this product with caution as ginseng may stimulate the growth of breast cancer cells (9).
No significant reactions reported
Vuksan V, et al. American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Arch Intern Med 2000;160:1009-13.
A small open label evaluation of American ginseng extract on healthy (n=10) and type II diabetic (n=9) subjects. Patients were given 3 grams American ginseng extract or placebo prior to 25 gram glucose tolerance test on four separate occasions. Nondiabetic and diabetic subjects had significantly lower glucose concentrations 40 minutes after glucose administration. No adverse effects were noted during the study. The author suggests that American ginseng extract reduces postprandial glucose concentrations by an unknown mechanism. Additional studies are required to understand the effects of chronic American ginseng administration.
Yuan CS, et al. Brief Communication: American Ginseng reduces Warfarin’s effect in healthy patients. Annals of Internal Medicine 2004;141:23-27.
Twenty healthy adults took part in a four-week trial of ginseng and its effects on warfarin. All subjects received warfarin during week 1 and 4. Subjects were randomly assigned to receive either 1.0 gram American ginseng or placebo twice daily starting in week 2. Subjects receiving ginseng had significantly decreased International Normalized Ratios (INR) when compared with those receiving placebo. Peak INR and peak plasma warfarin levels were correlated. Researchers conclude that ginseng reduces warfarin’s anticoagulant effect and suggest that physicians ask their patients about ginseng use before prescribing warfarin.
Bottom Line: American ginseng is NOT an effective treatment for cancer or any other serious disease. It does not improve athletic performance.
American ginseng has been shown to lower blood sugar levels in humans. Scientists think that the effects of ginseng come from components of the botanical called ginsenosides. Little research has been done on it, either in the laboratory or in people. However, we do have some research on Panax ginseng, which is an Asian form of ginseng. This research indicates that the ginsenosides both stimulate and inhibit the central nervous system in humans and stimulate the immune system in mice. Laboratory studies in mice and population studies in humans suggest that Panax ginseng might have cancer-preventative properties, but this is uncertain. In a recent study, American ginseng has been shown to decrease the anticoagulant effects of warfarin.
Diabetes:
The effects of ginseng have been studied on ten healthy men and 9 people with diabetes. Subjects were given 3 grams of either American ginseng or a placebo before a glucose tolerance test on four separate occasions. All subjects had lower glucose concentrations 40 minutes after taking glucose. No adverse effects were noted. Further studies have been suggested to understand the effects of long-term use of ginseng.
Do not use ginseng for more than one month.